Literature DB >> 31050352

Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.

Kemar V Prussien1, Lori C Jordan2, Michael R DeBaun2, Bruce E Compas1.   

Abstract

OBJECTIVE: To provide a comprehensive quantitative review of neurocognitive function in sickle cell disease (SCD) across multiple domains, cerebral infarct status, and the lifespan.
METHODS: One hundred and ten studies were identified in PubMed, MedLine, and PsycINFO involving 110 studies of 3,600 participants with SCD and 1,127 sibling or health controls.
RESULTS: Meta-analytic findings indicate significant deficits across all neurocognitive domains, age groups, and infarct status. Significant deficits relative to the normative mean ranged from Hedges' g = -.39 to g = -.63 in preschool children, g = -.83 to g = -1.18 in school-aged children and adolescents, and g = -.46 to g = -.86 in adults. Deficits in full scale IQ (FSIQ), verbal reasoning, perceptual reasoning, and executive function increased from preschool to school-aged samples. However, findings also showed that deficits were smaller in adult samples relative to school-aged samples, likely due to sampling bias in adult studies. Findings across infarct status in sickle cell anemia showed that deficits ranged from g = -.54 to g = -.65 in samples without infarcts, g = -.52 to g = -1.03 in samples with silent cerebral infarct, and g = -1.35 to g = -1.82 in samples with stroke. Deficits in each domain increased in magnitude from no infarct or stroke, to silent cerebral infarct, to overt stroke.
CONCLUSION: Individuals with SCD are at risk for cognitive deficits across domains, infarct status, and the lifespan. More research is necessary to determine unbiased effects for cognitive function in adults with SCD.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Pediatric Psychology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adult; age; cerebral infarct; cognitive function; preschool; school-age; sickle cell disease; stroke

Mesh:

Year:  2019        PMID: 31050352      PMCID: PMC6706005          DOI: 10.1093/jpepsy/jsz031

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  29 in total

1.  Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.

Authors:  S Duval; R Tweedie
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

Review 2.  Cognitive functioning in children with sickle cell disease: a meta-analysis.

Authors:  Jeffrey Schatz; Robert L Finke; Julie M Kellett; Joel H Kramer
Journal:  J Pediatr Psychol       Date:  2002-12

Review 3.  Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.

Authors:  Leslie D Berkelhammer; Adrienne L Williamson; Stacy D Sanford; Courtney L Dirksen; William G Sharp; Allison S Margulies; Rebecca A Prengler
Journal:  Child Neuropsychol       Date:  2007-03       Impact factor: 2.500

4.  Executive function, working memory, and medication adherence among older adults.

Authors:  Kathleen Insel; Daniel Morrow; Barbara Brewer; Aurelio Figueredo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

5.  Individual differences in executive functions are almost entirely genetic in origin.

Authors:  Naomi P Friedman; Akira Miyake; Susan E Young; John C DeFries; Robin P Corley; John K Hewitt
Journal:  J Exp Psychol Gen       Date:  2008-05

Review 6.  Neuropsychological aspects of pediatric sickle cell disease.

Authors:  M C Kral; R T Brown; G W Hynd
Journal:  Neuropsychol Rev       Date:  2001-12       Impact factor: 7.444

Review 7.  Recent advances in improving the management of sickle cell disease.

Authors:  Adlette Inati
Journal:  Blood Rev       Date:  2009-12       Impact factor: 8.250

8.  Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

Authors:  Margaret T Lee; Sergio Piomelli; Suzanne Granger; Scott T Miller; Shannon Harkness; Donald J Brambilla; Robert J Adams
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

9.  The excess burden of stroke in hospitalized adults with sickle cell disease.

Authors:  John J Strouse; Lori C Jordan; Sophie Lanzkron; James F Casella
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

10.  Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit.

Authors:  R Grant Steen; Mark A Miles; Kathleen J Helton; Susan Strawn; Winfred Wang; Xiaoping Xiong; Raymond K Mulhern
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

View more
  32 in total

1.  Brief Screening Measures Identify Risk for Psychological Difficulties Among Children with Sickle Cell Disease.

Authors:  Anna M Hood; Ilana Reife; Allison A King; Desiree A White
Journal:  J Clin Psychol Med Settings       Date:  2020-12

2.  Responsive Parenting Behaviors and Cognitive Function in Children With Sickle Cell Disease.

Authors:  Janet Yarboi; Kemar V Prussien; Heather Bemis; Ellen Williams; Kelly H Watson; Collen McNally; Lauren Henry; Allison A King; Michael R DeBaun; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2019-11-01

3.  Correlates of Cognitive Function in Sickle Cell Disease: A Meta-Analysis.

Authors:  Kemar V Prussien; Rachel E Siciliano; Abagail E Ciriegio; Allegra S Anderson; Radha Sathanayagam; Michael R DeBaun; Lori C Jordan; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2020-03-01

4.  Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease.

Authors:  Kemar V Prussien; Dilan A Patel; Karina Wilkerson; Becky Armstrong; Leena Karnik; Josu de la Fuente; Adetola A Kassim
Journal:  Pediatr Blood Cancer       Date:  2019-10-08       Impact factor: 3.167

5.  Preliminary Study of Coping, Perceived Control, and Depressive Symptoms in Youth with Sickle Cell Anemia.

Authors:  Kemar V Prussien; Rachel E Siciliano; Abagail E Ciriegio; Chelsea A Lee; Michael R DeBaun; Lori C Jordan; Bruce E Compas
Journal:  J Dev Behav Pediatr       Date:  2021-08-01       Impact factor: 2.988

6.  Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium.

Authors:  Shannon Phillips; Alyssa M Schlenz; Martina Mueller; Cathy Melvin; Robert J Adams; Julie Kanter
Journal:  Pediatr Blood Cancer       Date:  2020-09-07       Impact factor: 3.167

7.  Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia.

Authors:  Kemar V Prussien; Bruce E Compas; Rachel E Siciliano; Abagail E Ciriegio; Chelsea A Lee; Adetola A Kassim; Michael R DeBaun; Manus J Donahue; Lori C Jordan
Journal:  Stroke       Date:  2021-04-12       Impact factor: 7.914

8.  Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia.

Authors:  Kristine Karkoska; Charles T Quinn; Omar Niss; Amanda Pfeiffer; Min Dong; Alexander A Vinks; Patrick T McGann
Journal:  Am J Hematol       Date:  2021-02-19       Impact factor: 10.047

9.  Academic Challenges and School Service Utilization in Children with Sickle Cell Disease.

Authors:  Kristine A Karkoska; Kenneth Haber; Megan Elam; Sarah Strong; Patrick T McGann
Journal:  J Pediatr       Date:  2020-12-01       Impact factor: 4.406

10.  Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.

Authors:  Jennifer N Longoria; Norma L Pugh; Victor Gordeuk; Lewis L Hsu; Marsha Treadwell; Allison A King; Robert Gibson; Mariam Kayle; Nancy Crego; Jeffrey Glassberg; Cathy L Melvin; Jane S Hankins; Jerlym Porter
Journal:  Am J Hematol       Date:  2021-08-24       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.